Homocysteine as a predictor of cognitive decline in Alzheimer's disease
Objective: Moderately elevated levels of plasma total homocysteine are associated with an increased risk of developing Alzheimer's disease. We have tested whether baseline concentrations of homocysteine relate to the subsequent rate of cognitive decline in patients with established Alzheimer...
Main Authors: | Oulhaj, A, Refsum, H, Beaumont, H, Williams, J, King, E, Jacoby, R, Smith, A |
---|---|
Other Authors: | International College of Geriatric Psychoneuropharmacology |
Format: | Journal article |
Language: | English |
Published: |
John Wiley & Sons, Ltd.
2010
|
Subjects: |
Similar Items
-
Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
by: Oulhaj, A, et al.
Published: (2010) -
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
by: Smith, A, et al.
Published: (2010) -
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
by: de Jager, C, et al.
Published: (2012) -
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
by: De Jager, C, et al.
Published: (2012) -
Cognitive deficits in severe mood disorder: similar or different from schizophrenia?
by: Goodwin, G
Published: (2003)